{"id":"https://openalex.org/W2981111797","doi":"https://doi.org/10.1016/j.vhri.2019.08.101","title":"PCN33 PERTUZUMAB+TRASTUZUMAB TREATMENT ON HER2+ EARLY BREAST CANCER: LONG-TERM REDUCTION OF METASTASIC BREAST CANCER INCIDENCE IN ARGENTINA.","display_name":"PCN33 PERTUZUMAB+TRASTUZUMAB TREATMENT ON HER2+ EARLY BREAST CANCER: LONG-TERM REDUCTION OF METASTASIC BREAST CANCER INCIDENCE IN ARGENTINA.","publication_year":2019,"publication_date":"2019-10-01","ids":{"openalex":"https://openalex.org/W2981111797","doi":"https://doi.org/10.1016/j.vhri.2019.08.101","mag":"2981111797"},"language":"en","primary_location":{"id":"doi:10.1016/j.vhri.2019.08.101","doi":"https://doi.org/10.1016/j.vhri.2019.08.101","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vhri.2019.08.101","pdf_url":null,"source":{"id":"https://openalex.org/S2764833115","display_name":"Value in Health Regional Issues","issn_l":"2212-1099","issn":["2212-1099","2212-1102"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","medline","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health Regional Issues","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.vhri.2019.08.101","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016719377","display_name":"N. Penayo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"N. Penayo","raw_affiliation_strings":["F.Hoffmann La Roche Ltd, Derqui, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F.Hoffmann La Roche Ltd, Derqui, Argentina","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":null,"display_name":"F. Ferrari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"F. Ferrari","raw_affiliation_strings":["F.Hoffmann La Roche Ltd, Ricardo Rojas \u2013 Tigre, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F.Hoffmann La Roche Ltd, Ricardo Rojas \u2013 Tigre, Argentina","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007402401","display_name":"Mariano Nicolas Carrizo","orcid":"https://orcid.org/0000-0003-0932-1102","observed_orcids":["https://orcid.org/0000-0003-0932-1102"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"M. Carrizo","raw_affiliation_strings":["F.Hoffmann La Roche Ltd, Ricardo Rojas \u2013 Tigre, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F.Hoffmann La Roche Ltd, Ricardo Rojas \u2013 Tigre, Argentina","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004351007","display_name":"Francisco E. Tellechea","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"F. Tellechea","raw_affiliation_strings":["F.Hoffmann La Roche Ltd, Ricardo Rojas \u2013 Tigre, B, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F.Hoffmann La Roche Ltd, Ricardo Rojas \u2013 Tigre, B, Argentina","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I118019719"],"apc_list":{"value":1500,"currency":"USD","value_usd":1500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"19","issue":null,"first_page":"S19","last_page":"S19"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9595000147819519,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9595000147819519,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.015399999916553497,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.014399999752640724,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":0.9800000190734863},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9670000076293945},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9739999771118164},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.8479999899864197},{"id":"https://openalex.org/keywords/incidence-reduction","display_name":"incidence reduction","score":0.5529999732971191},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.8500000238418579},{"id":"https://openalex.org/keywords/argentina","display_name":"Argentina","score":0.4090000092983246},{"id":"https://openalex.org/keywords/cost-reduction","display_name":"cost reduction","score":0.5090000033378601},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.48899999260902405},{"id":"https://openalex.org/keywords/node-positive-breast-cancer","display_name":"node-positive breast cancer","score":0.7049999833106995}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8239985108375549},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.7953295111656189},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7396048307418823},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6697946190834045},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5843080282211304},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5706664323806763},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5494616627693176},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4875154197216034},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.46377936005592346},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.4205710291862488},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39036282896995544},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.09572374820709229},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.06204003095626831},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.vhri.2019.08.101","doi":"https://doi.org/10.1016/j.vhri.2019.08.101","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vhri.2019.08.101","pdf_url":null,"source":{"id":"https://openalex.org/S2764833115","display_name":"Value in Health Regional Issues","issn_l":"2212-1099","issn":["2212-1099","2212-1102"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","medline","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health Regional Issues","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.vhri.2019.08.101","doi":"https://doi.org/10.1016/j.vhri.2019.08.101","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vhri.2019.08.101","pdf_url":null,"source":{"id":"https://openalex.org/S2764833115","display_name":"Value in Health Regional Issues","issn_l":"2212-1099","issn":["2212-1099","2212-1102"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","medline","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health Regional Issues","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2810215276","https://openalex.org/W4382010602","https://openalex.org/W2766967869","https://openalex.org/W2241856749","https://openalex.org/W2906460776","https://openalex.org/W3113277757","https://openalex.org/W4243633398","https://openalex.org/W2996344466","https://openalex.org/W2979267858","https://openalex.org/W4285194258"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2019-10-25T00:00:00"}